Standout Papers

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a rando... 2022 2026 2023 2024154
  1. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022)
    Felix Mahfoud, David E. Kandzari et al. The Lancet

Immediate Impact

25 standout
Sub-graph 1 of 12

Citing Papers

Chronic kidney disease
2025 Standout
Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden
2024 Standout
2 intermediate papers

Works of Andrew Sharp being referenced

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
2022 Standout

Author Peers

Author Last Decade Papers Cites
Andrew Sharp 205 27 47 52 51 11 282
Aydin M. Bilgutay 192 37 97 47 13 13 314
Remzi Önder 241 21 99 7 17 23 312
Sadaf Esteghamati 71 6 48 31 13 19 249
Willemien L. Verloop 248 29 47 14 32 16 284
Elaine Loughlin 175 53 40 51 17 10 324
Antonietta Cardinale 184 138 34 30 20 8 330
B Francucci 67 32 39 4 26 12 330
M. Kwapisz 126 56 122 5 21 16 272
N M Kaplan 152 15 31 3 27 15 264
C. C. Toner 33 64 120 10 123 10 332

All Works

Loading papers...

Rankless by CCL
2026